Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study-Reference-Cited by-同舟云学术

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Published:2001-11 Issue:11 Volume:29 Page:2081-2089
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Abraham Edward,Reinhart Konrad,Svoboda Petr,Seibert Allan,Olthoff Derk,Dal Nogare Anthony,Postier Russell,Hempelmann Gunter,Butler Thomas,Martin Eike,Zwingelstein Christian,Percell Sandra,Shu Vincent,Leighton Anton,Creasey Abla A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference23 articles.

1. SEVERE SEPSIS AND SEPTIC SHOCK

2. Disseminated Intravascular Coagulation

3. Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

4. Structural design and molecular evolution of a cytokine receptor superfamily.

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage;Research and Practice in Thrombosis and Haemostasis;2024-07

2. Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock;Scientific Reports;2024-06-24

3. Septic Coagulopathy: Pathophysiology, Diagnosis, and Therapeutic Strategies;Current Infectious Disease Reports;2024-01-22

4. Efficacy and Safety of Anticoagulant Therapy in Patients with Sepsis: A Meta-Analysis of Randomized Controlled Trials;2024

5. Transition of the criteria for disseminated intravascular coagulation;Japanese Journal of Thrombosis and Hemostasis;2024